trending Market Intelligence /marketintelligence/en/news-insights/trending/gI4moMasS09EjAoW9erIrA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Harrow Health to sell subsidiary's assets to Noice for $8M

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Harrow Health to sell subsidiary's assets to Noice for $8M

Harrow Health Inc. agreed to sell all assets of its wholly owned unit Park Compounding Inc. that are related to the compounding business of pharmaceuticals not used for eye care to Noice Rx LLC for $8 million.

Under the deal, Harrow Health will issue Noice an $8 million note at an annual interest of 9.5%. In turn, Noice will make 96 monthly cash payments to Harrow Health over an eight-year period after the closing.

Harrow Health will also receive a warrant that can be exercised after five years to own a 20% stake in Noice.

Harrow Health expects to close the transaction on or before Aug. 27, subject to closing conditions including a temporary pharmacy and sterile license permit from the California State Board of Pharmacy.